Skip to content
akaturk Academic measurement

Article detail · 2020 · article

SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients

ISSN1303-6092
YÖKSİS OpenAlex Open access · diamond TR Index
Year2020
Citations27OpenAlex
Citations30Semantic Scholar
Percentile%79.9
FWCI0.571.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q3

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueTURKISH JOURNAL OF BIOLOGY
  • Catalog match (ISSN)Turkish Journal of Biology
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

The novel coronavirus pneumonia, which was named later as coronavirus disease 2019 (COVID-19), is caused by the severe acute respiratory syndrome coronavirus 2, namely SARS-CoV-2. It is a positive-strand RNA virus that is the seventh coronavirus known to infect humans. The COVID-19 outbreak presents enormous challenges for global health behind the pandemic outbreak. The first diagnosed patient in Turkey has been reported by the Republic of Turkey Ministry of Health on March 11, 2020. In May, over 150,000 cases in Turkey, and 5.5 million cases around the world have been declared. Due to the urgent need for a vaccine and antiviral drug, isolation of the virus is crucial. Here, we report 1 of the first isolation and characterization studies of SARS-CoV-2 from nasopharyngeal and oropharyngeal specimens of diagnosed patients in Turkey. This study provides an isolation and replication methodology,and cell culture tropism of the virus that will be available to the research communities.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

27citationsOpenAlex · cited_by_count (cache / database)

40 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2021 Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics.Citations 50 · OpenAlex
  2. 2021 Gene editing and RNAi approaches for COVID-19 diagnostics and therapeuticsCitations 50 · OpenAlex
  3. 2021 Gene editing and RNAi approaches for COVID-19 diagnostics and therapeuticsCitations 50 · OpenAlex
  4. 2020 Gene editing and RNAi approaches for COVID-19 diagnostics and therapeuticsCitations 50 · OpenAlex
  5. 2022 Comparison of COVID‐19 laboratory diagnosis by commercial kits: Effectivity of RT‐PCR to the RT‐LAMPCitations 49 · OpenAlex
  6. 2022 COMPARISON OF COVID-19 LABORATORY DIAGNOSIS BY COMMERCIAL KITS: EFFECTIVITY OF RT-PCR TO THE RT-LAMPCitations 49 · OpenAlex
  7. 2020 Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infectionCitations 49 · OpenAlex
  8. 2020 Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infectionCitations 49 · OpenAlex
  9. 2020 Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infectionCitations 49 · OpenAlex
  10. 2020 Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infectionCitations 49 · OpenAlex

Authors

18
  1. CİHAN TAŞTAN ÜSKÜDAR ÜNİVERSİTESİ 1
  2. bulut Yurtsever 2
  3. Gözde Sır Karakus 3
  4. Derya Dilek Kancağı 4
  5. Sevda Demir 5
  6. Selen Abanuz 6
  7. Utku Seyis 7
  8. Mülazim Yıldırım 8
  9. Recai Kuzay 9
  10. Ömer Elibol 10
  11. Serap Arbak 11
  12. Merve Açıkel Elmas 12
  13. Selçuk Birdoğan 13
  14. OSMAN UĞUR SEZERMAN 14
  15. AYŞE SESİN KOCAGÖZ 15
  16. KORAY YALÇIN ACIBADEM MEHMET ALİ AYDINLAR ÜNİVERSİTESİ 16
  17. ERCÜMENT OVALI 17
  18. DERYA DİLEK KANÇAĞI FENERBAHÇE ÜNİVERSİTESİ 18